Development and validation of diagnostic methods for veterinary fungal pathogensto support network-wide standardization
Active Cooperative Agreement Awarded
- Award ID
- U18FD008940
- Recipient
-
University Of Georgia Research Foundation, Inc. UEI NMJHD63STRC5
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $186,203
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date 18% complete
- Funding agency
- Food and Drug Administration Department of Health and Human Services
- Place of performance
- Athens, GA 30602, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services Food and Drug Administration awarded Cooperative Agreement U18FD008940 to University of Georgia Research Foundation, Inc. (doing business as UGA Research Foundation), obligating $186,203 on September 23, 2026, under Food and Drug Administration Research (Assistance Listing 93.103).
The project develops, validates, and standardizes antifungal susceptibility testing (AFST) and whole-genome sequencing (WGS) workflows for clinically relevant veterinary fungal pathogens to support implementation across VET-LIRN laboratories. Planned work includes systematic optimization of organism-specific variables, evaluation of broth microdilution, gradient diffusion, and terbinafine-specific screening platforms, inclusion of filamentous fungi and dermatophytes, and development of transferable workflows suited to laboratories with varying levels of infrastructure. The project also establishes a standardized WGS pipeline built on accessible bioinformatic platforms.
The period of performance runs through August 31, 2027. Place of performance is Athens, GA 30602, USA.
The parent program assists institutions and organizations to establish, expand, and improve research, demonstration, education, and information dissemination activities.
Description
- Abstract
- Fungal infections are an underrecognized but growing threat to animal and public health, contributing to significant morbidity and emerging concerns related to antifungal resistance. Despite increasing recognition of their clinical impact, fungal diseases remain underdiagnosed, and diagnostic and surveillance frameworks are lacking in veterinary medicine. Unlike bacterial pathogens, where standardized antimicrobial susceptibility testing and genomic surveillance are well established, comparable approaches for veterinary fungal pathogens remain largely undeveloped. Current diagnostics rely primarily on culture-based methods and limited molecular tools, while antifungal susceptibility testing (AFST) is rarely applied and often outsourced to human clinical reference laboratories. Whole- genome sequencing (WGS) is also not routinely integrated into veterinary diagnostic workflows. Together, these gaps limit clinical decision-making, antifungal stewardship, and surveillance capacity. The overall objective of this project is to develop, validate, and standardize AFST and WGS workflows for clinically relevant veterinary fungal pathogens to support implementation across VET-lirn laboratories. We will address these critical gaps by establishing harmonized, laboratory-ready workflows tailored specifically to veterinary mycology. Key innovations include systematic optimization of organism-specific variables, evaluation of complementary AFST platforms (broth microdilution, gradient diffusion, and terbinafine-specific screening), inclusion of challenging organisms such as filamentous fungi and dermatophytes, and development of practical, transferable workflows suitable for laboratories with varying levels of infrastructure. In parallel, we will establish a standardized WGS pipeline using accessible bioinformatic platforms compatible with routine diagnostic use. While not intended to address all aspects of antifungal resistance or genomic discovery within the project period, these efforts will generate essential infrastructure and standardized datasets to support future studies on resistance mechanisms, breakpoint development, and future fungal disease surveillance ATA national level. This project establishes a critical foundation for expanding veterinary fungal diagnostics and antifungal resistance monitoring within a one health framework.
Quick answers
Who received award U18FD008940?
U18FD008940 was awarded to University Of Georgia Research Foundation, Inc. by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.
How much is award U18FD008940 worth?
$186,203 has been obligated on U18FD008940.
Which agency awarded U18FD008940?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008940, with funding from Food and Drug Administration (Department of Health and Human Services).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award